News
US Healthcare: Star Trek innovation and Flintstones delivery. Patients deserve better.
Reflections from the Galien Patient Summit and Forum by Susan Manber, WSCN Chief Patient Officer
I left the Galien Patient Summit and Forum (Oct 29th, 2026) inspired by extraordinary scientific advances, and challenged by how much work remains to ensure those breakthroughs translate into better lives for more people.
The summit honored the legacy of Galien Founder Elie Wiesel and his conviction that science and innovation must serve humanity with dignity, compassion and justice.
Across conversations with patient advocates, scientists, regulators and industry leaders, one question kept surfacing: Are we as committed to transforming how healthcare works for people as we are to advancing the science itself?
Five themes stood out.
1. Our greatest challenge may not be discovery. It’s delivery.
“Star Trek innovation and Flintstones delivery.”
We have some of the world’s most advanced medical practices in the US, and yet people are not experiencing the benefits because we are failing to connect them to treatment pathways.
Drawing on a 1976 philosophical essay on human fallibility by Samuel Gorovitz and Alasdair MacIntyre), Gawande categorizes human error into two distinct buckets to explain why even highly trained experts still make fatal mistakes:
- Ignorance = Lack of knowledge
- Ineptitude = Failure to execute
Consider Hepatitis C. In the US we have highly effective curative treatments, yet we still have the same 2.4 million people living with Hep C because patients continue to fall through gaps in testing, diagnosis and treatment.
Gawande’s work with surgical safety checklists offers a clear example of the opposite: simple changes in coordination and execution in surgical theaters reduced complications by 36% and deaths by 47% in an international study.
No breakthrough molecule required – improving the way a pre-existing service was delivered made a significant impact without requiring a new drug therapy or technology to be introduced.
His larger point resonated deeply: healthcare is increasingly complex, requiring many people and capabilities to work together around individual needs.
Innovation without execution isn’t enough. We need to redesign the system so breakthroughs actually reach people.
2. Nothing about patients without patients
We’ve talked about putting patients first for decades. It’s time to move from lip-service level listening to patients toward genuinely sharing decision-making in healthcare.
Kathy Giusti’s work on multiple myeloma shows what’s possible when patients help lead research. She brought patients together, helped build systems to collect and share data, and challenged traditional approaches. Her efforts helped speed up progress against a disease that was once considered universally incurable.
One observation stayed with me: patients’ greatest fear is missing out: Missing a clinical trial. A breakthrough therapy. Information that could change a treatment decision.
The opportunity isn’t simply providing more information. It’s equipping people with credible evidence, better questions, peer support and meaningful access to innovation.
3. Design clinical trials around living, not just surviving
The discussion on patient-focused clinical trials showed why patients should be involved earlier, even before final decisions are made about developing new drugs.
Patients challenged requirements that can make participation unnecessarily burdensome: Repeated bone marrow biopsies, twice-daily fasting regimens and endpoints that overlook quality of life. In psoriasis, clear skin may be the traditional measure of success. But patients care most about itching and pain.
These aren’t secondary considerations. They define treatment value and should be included from the very start of a research project.
Patient-informed endpoints, personalized dosing and smarter study designs can potentially generate better evidence with less burden, and create treatments that truly meet patient’s needs and wishes for better health.
We need to shift from asking, “How do we recruit patients into our trials?” to “How do we design trials patients can and want to participate in?”
4. AI’s greatest promise lies in empowering people, not replacing them
AI was everywhere in the conversation. But the most compelling applications addressed real human needs.
The Epilepsy Foundation’s empathetic chatbot, Sage, and Tempus’s patient-facing tools illustrate the potential to help people navigate increasingly complex healthcare information.
Imagine every patient being able to understand current peer-reviewed evidence, identify relevant clinical trials and prepare five meaningful questions for their physician.
Yet technology alone won’t fix fragmented healthcare.
AI is only as valuable as the evidence informing it and the human decisions it enables.
The opportunity is human ingenuity amplified by AI—not AI as a substitute for human judgment, relationships or coordinated care.
5. Breakthroughs require collaboration beyond traditional boundaries
A highlight of the summit was the biopharma CEO leadership forum, moderated by Ken Frazier and featuring Dr. Yvonne Greenstree, CEO of Anylam; Olivier Laureau, CEO of Laboratoires Servier; and George Yancopoulos, CEO and Chief Scientific Officer of Regeneron.
The forum reinforced the conviction, resilience, and long-term investment required to turn scientific possibilities into medicines.
But another opportunity deserves attention: connecting promising scientific assets, patient needs, advocacy organizations and alternative funding models in ways traditional structures often overlook.
-
Why should promising science languish because it doesn’t fit a company’s immediate priorities?
-
Why should patients wait for organizations to overcome treatment silos and barriers between areas of care that have little relevance to their needs?
Innovation must extend beyond molecules to the partnerships, business models and ways of working that make progress possible.
From patient-centered care to patient value
My biggest takeaway is that we need to change the questions we’re asking.
Instead of asking: How do we bring patients into what we’re already doing?
We need to be asking: Where are the greatest unmet human needs? What’s preventing us from addressing them? And how do we bring together the right science, people, capabilities and partnerships to help?
This is precisely the challenge we’re taking on through the Wellness Sleep & Circadian Network (WSCN): helping people take ownership of their health across all 24 hours, while bringing together diverse disciplines and advocacy communities in true partnership for better impact.
Because ultimately, the measure of healthcare innovation isn’t simply what science makes possible.
It’s what we make possible for people.
Written by Susan Manber. WSCN Board and Chief Patient Officer.
Key Takeaways
- Our greatest challenge may not be discovery – it’s delivery.
- Nothing about patients without patients.
- Design clinical trials around living, not just surviving.
- AI’s greatest promise lies in empowering people.
- Breakthroughs require collaboration.
